Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N V Dimitrov

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
American Journal of Clinical Oncology|October 1, 1988
High-dose folinic acid and 5-fluorouracil in the treatment of advanced colon cancerA P Scholnik, D J Arnold, W S Walker, et al.
The American Journal of Clinical Nutrition|June 1, 1990
Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjectsN V Dimitrov, C J Meyer, M Perloff, et al.
Annals of Internal Medicine|November 1, 1989
Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trialsB Fisher, C Redmond, D L Wickerham, et al.
The New England Journal of Medicine|February 23, 1989
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumorsB Fisher, J Costantino, C Redmond, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Oltipraz concentrations in plasma, buccal mucosa cells, and lipids: pharmacological studiesN V Dimitrov, C M Leece, E R Tompkins, et al.
The New England Journal of Medicine|February 23, 1989
A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumorsB Fisher, C Redmond, N V Dimitrov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15B Fisher, A M Brown, N V Dimitrov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16B Fisher, C Redmond, S Legault-Poisson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04N Wolmark, H Rockette, E Mamounas, et al.
Journal of the National Cancer Institute|December 9, 1997
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancerB Fisher, J Dignam, N Wolmark, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
American Journal of Clinical Oncology|October 1, 1988
High-dose folinic acid and 5-fluorouracil in the treatment of advanced colon cancerA P Scholnik, D J Arnold, W S Walker, et al.
The American Journal of Clinical Nutrition|June 1, 1990
Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjectsN V Dimitrov, C J Meyer, M Perloff, et al.
Annals of Internal Medicine|November 1, 1989
Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trialsB Fisher, C Redmond, D L Wickerham, et al.
The New England Journal of Medicine|February 23, 1989
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumorsB Fisher, J Costantino, C Redmond, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Oltipraz concentrations in plasma, buccal mucosa cells, and lipids: pharmacological studiesN V Dimitrov, C M Leece, E R Tompkins, et al.
The New England Journal of Medicine|February 23, 1989
A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumorsB Fisher, C Redmond, N V Dimitrov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15B Fisher, A M Brown, N V Dimitrov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16B Fisher, C Redmond, S Legault-Poisson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04N Wolmark, H Rockette, E Mamounas, et al.
Journal of the National Cancer Institute|December 9, 1997
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancerB Fisher, J Dignam, N Wolmark, et al.
Pageof 5